Nx2me Connected Health®

A state of the art telehealth platform for the collection and delivery of home hemodialysis treatment and patient medical information.

Nx2me Connected Health is designed to help you:

  • Monitor and support patient adherence and potentially reduce complications
  • Reduce patient burden and enhance patient confidence
  • Increase patient retention through compliance monitoring and enhanced connection with patients
  • Reduce effort involved in collecting flowsheets

Quality of Care: Key Benefits

Compliance:
Clinicians may monitor and support adherence to treatment and potentially reduce complications and hospitalizations associated with non-compliance.

Early intervention:
Clinicians may identify health problems before unscheduled care is needed (eg, blood pressures, arterial or venous pressures running too high).

Notifications:
Alerts patients and nurses when key clinical parameters deviate from pre-established norm to help support patient case management.

Data captured from the patients and available to clinicians include:

  • Patient’s weight and blood pressure (captured via Bluetooth® technology)
  • Fluid weight removed during treatment
  • Medications taken
  • Dialysis fluid delivered
  • Notes, and health assessments
    • Two-way messaging system, similar to text messaging, enhances communication and care coordination

Once your patient finishes their treatments, data recorded in the Nx2me app, will be transmitted directly to the Nx2me Clinician Portal where you can access their treatment record 24/7 for a closer look.

Nx2me works over a secure Wi-Fi network established at the patient’s home. If a patient doesn’t have Internet service, a cell data plan is available. All patient information is encrypted and transmitted using secured Internet protocols.

Nx2me has shown to improve patient retention by monitoring compliance, early intervention and education.1

32% Lower overall therapy discontinuation rate
44% Lower therapy discontinuation rate in new patients

 

Bluetooth is a registered trademark of SIG, Inc.

References:
  1. Weinhandl E, Molina J, Collins A. Lower Risk of Home Hemodialysis Attrition in Patients Using Nx2me Connected Health Technology. Abstract presented at Annual Dialysis Conference. February, 2016.
  • For more information on the Nx2me Connected Health, call NxStage at 1-866-NXSTAGE (697-8243) or fill out the form to speak with an expert.

Risks and Responsibilities

The reported benefits of home hemodialysis (HHD) may not be experienced by all patients.

The NxStage System is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.

Home hemodialysis with the NxStage System during waking hours may not require a care partner, provided a physician and a qualified patient agree that solo home hemodialysis is appropriate. Patients performing nocturnal treatments are required to have a care partner. Care partners are trained on proper operation and how to get medical or technical help if needed.

Certain risks associated with hemodialysis treatment are increased when performing solo HHD because no one is present to help the patient respond to health emergencies. If patients experience needles coming out, blood loss, or very low blood pressure during solo HHD, they may lose consciousness or become physically unable to correct the health emergency. Losing consciousness or otherwise becoming impaired during any health emergency while alone could result in significant injury or death. Additional ancillary devices and training are required when performing solo HHD.

Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow and/or increased treatment time, and delayed response to alarms when waking from sleep.

Patients should consult their doctor to understand the risks and responsibilities of performing these therapies using the NxStage System.